Brand Pharma Gets "Clear And Convincing" Patent Win At The Supreme Court
This article was originally published in The Pink Sheet Daily
Executive Summary
Brand name and generic companies had taken opposite sides in a case in which Microsoft sought to lower the standard for invalidating a patent from "clear and convincing evidence" to "preponderance of the evidence."